• Home
  • About Atom
    • Management Team
    • Advisory Board
    • Investors
  • Our Programs
    • Pipeline
    • Gout & Hyperuricemia
    • NASH
  • News & Events
  • Contact Us

Post navigation

Previous PostAtom Bioscience completes about $30 million in Series B financing
Next PostAtom Bioscience to Present at Biotech Showcase January 10-12, 2022

Follow us on

  • Home
  • About Atom
  • Our Programs
  • News & Events
  • Contact Us

©2022 Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.